The Role of Galectin-1 in Duchenne Muscular Dystrophy Disease Progression

Loading...
Thumbnail Image

Authors

Tice, Jordan

Issue Date

2016

Type

Thesis

Language

en_US

Keywords

Research Projects

Organizational Units

Journal Issue

Alternative Title

Abstract

Duchenne Muscular Dystrophy (DMD) is a genetic disorder caused by mutations in the dystrophin gene and affects 1 out of 5,000 male children (Heller et al.). Patients who are diagnosed with this life-threatening disease usually suffer from respiratory failure due to irreversible effects on the diaphragm resulting in premature death. Mdx mice have the same dysfunctional dystrophin gene as patients and are the standard mouse model used for DMD. No cure for this devastating disease exists. The Burkin Lab at the University of Nevada, Reno has shown that mdx mice treated with recombinant Galectin-1 protein exhibit improved skeletal muscle viability and pathology. However, the mechanisms of these improvements have yet to be elucidated. This study has provided evidence that Galectin-1 plays a role in the mechanism and pathology of DMD for potential uses as a protein treatment therapy in patients afflicted with the disease.

Description

The University of Nevada, Reno Libraries will promptly respond to removal requests related to content that violates intellectual property laws, data protections, or has been uploaded without creator consent. Takedown notices should be directed to our ScholarWolf team (scholarwolf@library.unr.edu) with information about the object, including its full URL and the nature of your complaint.

Citation

Publisher

License

In Copyright

Journal

Volume

Issue

PubMed ID

DOI

ISSN

EISSN